RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE

分支小胶质细胞和慢病毒的持久性

基本信息

  • 批准号:
    6540175
  • 负责人:
  • 金额:
    $ 19.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-07-01 至 2004-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (adapted from applicant's abstract): Neuronal injury and microglial activation are related processes that appear central to a number of chronic neurodegenerative diseases including AIDS dementia. Ramified tissue microglia are highly branched, quiescent cells that secrete neurotrophic factors. Generally, neuronal damage can be an important early trigger in activating ramified tissue microglia to become phagocytic macrophage-like cells. Uncontrolled activation of microglia results in release of a variety of substances that are toxic to bystander neurons. Conversely, healthy neurons and certain soluble factors oppose microglia activation by signaling microglia to maintain a quiescent, ramified phenotype, downregulate production of neurotoxic substances, and upregulate production of neurotrophic factors. Fine regulation of this reversible microglial activation/ramification cycle limits neuronal injury during infection or insult and favors regenerative healing following injury to the CNS. Clearance of cellular reservoirs that harbor HIV during HAART treatment is mainly dependent on the particular turnover rate of the reservoir target cell population. Most of the HIV-1-infected cells in the brain are macrophages and microglia. Ramified tissue microglia in the CNS represent one of the most stable cell types in the body and have one of the slowest turnover rates of any HIV target cell population that has been measured. Virus could persist in these quiescent cells for years or perhaps even decades before the cells turn over. However, since poorly characterized cellular interactions and unknown soluble factors mediate and maintain microglial ramification in the brain and because they are inaccessible, ramified microglia remain poorly understood. The investigators have developed neuron-rich organotypic brain slice cultures and dissociated cortical brain cultures that support microglial ramification and visna lentivirus infection in vitro. This type of system offers a unique opportunity to investigate the biology of the lentivirus-infected ramified microglia in neuron-rich, simulated brain microenvironments conducive to experimental manipulation and mechanistic studies. Such model systems could provide important insights into HIV persistence in the CNS. The central hypothesis is that HIV-infected cells in the brain include ramified tissue microglia with latent or restricted infection. Replication competent provirus persists in this cellular reservoir for prolonged periods in spite of treatment due to the extremely slow turnover rate of these cells and its location behind the blood brain barrier. We will test these hypotheses by: 1) improving and characterizing primary culture models of microglial ramification, 2) determining the effect of lentivirus infection microglial ramification, 3) identifying changes in susceptibility to lentivirus infection that occur during microglial ramification, and 4) characterizing markers and modulators of ramification of infected and uninfected microglia.
描述(改编自申请人摘要):神经元损伤和小胶质细胞

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID L HUSO其他文献

DAVID L HUSO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID L HUSO', 18)}}的其他基金

Cellular and Transgenic Phenotyping Core
细胞和转基因表型核心
  • 批准号:
    7651551
  • 财政年份:
    2009
  • 资助金额:
    $ 19.13万
  • 项目类别:
MENTORING IN MOUSE MOLECULAR PATHOBIOLOGY RESEARCH
小鼠分子病理学研究的指导
  • 批准号:
    6285897
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:
Mentoring in Mouse Molecular Pathobiology Research
小鼠分子病理学研究的指导
  • 批准号:
    6639835
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:
Mentoring in Mouse Molecular Pathobiology Research
小鼠分子病理学研究的指导
  • 批准号:
    6895607
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:
Mentoring in Mouse Molecular Pathobiology Research
小鼠分子病理学研究的指导
  • 批准号:
    6747715
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:
Mentoring in Mouse Molecular Pathobiology Research
小鼠分子病理学研究的指导
  • 批准号:
    6540556
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:
RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE
分支小胶质细胞和慢病毒的持久性
  • 批准号:
    6394248
  • 财政年份:
    1999
  • 资助金额:
    $ 19.13万
  • 项目类别:
RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE
分支小胶质细胞和慢病毒的持久性
  • 批准号:
    6188328
  • 财政年份:
    1999
  • 资助金额:
    $ 19.13万
  • 项目类别:
RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE
分支小胶质细胞和慢病毒的持久性
  • 批准号:
    6019902
  • 财政年份:
    1999
  • 资助金额:
    $ 19.13万
  • 项目类别:
NEURONAL DAMAGE RESULTING FROM LENTIVIRAL INFECTION
慢病毒感染引起的神经元损伤
  • 批准号:
    2655545
  • 财政年份:
    1996
  • 资助金额:
    $ 19.13万
  • 项目类别:

相似海外基金

The kynurenine pathway chemokines and MIC-1 in the pathogenesis of AIDS dementia complex.
犬尿氨酸途径趋化因子和 MIC-1 在艾滋病痴呆复合体发病机制中的作用
  • 批准号:
    nhmrc : 209548
  • 财政年份:
    2002
  • 资助金额:
    $ 19.13万
  • 项目类别:
    NHMRC Project Grants
MRS OF PATS W/ AIDS DEMENTIA COMPLEX: MULTICENTER ACTG 301 DRUG EVAL PROGRAM
患有艾滋病痴呆症的 PATS 夫人:多中心 ACTG 301 药物评估计划
  • 批准号:
    6657668
  • 财政年份:
    2002
  • 资助金额:
    $ 19.13万
  • 项目类别:
ACTG 301 TRIAL OF MEMANTINE FOR AIDS DEMENTIA COMPLEX (ADC)
ACTG 301 美金刚治疗艾滋病痴呆症 (ADC) 的试验
  • 批准号:
    6571869
  • 财政年份:
    2002
  • 资助金额:
    $ 19.13万
  • 项目类别:
NEUROLOGICAL EVALUATION OF THE AIDS DEMENTIA COMPLEX IN ACTG CLINICAL TRIALS
ACTG 临床试验中艾滋病痴呆症的神经学评估
  • 批准号:
    6445211
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:
MRS OF PATS W/ AIDS DEMENTIA COMPLEX: MULTICENTER ACTG 301 DRUG EVAL PROGRAM
患有艾滋病痴呆症的 PATS 夫人:多中心 ACTG 301 药物评估计划
  • 批准号:
    6495477
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:
ACTG 301--MEMANTINE FOR AIDS DEMENTIA COMPLEX WITH ANTIRETROVIRAL THERAPY
ACTG 301--美金刚联合抗逆转录病毒疗法治疗艾滋病痴呆症
  • 批准号:
    6565844
  • 财政年份:
    2001
  • 资助金额:
    $ 19.13万
  • 项目类别:
NEUROLOGICAL EVALUATION OF THE AIDS DEMENTIA COMPLEX IN ACTG CLINICAL TRIALS
ACTG 临床试验中艾滋病痴呆症的神经学评估
  • 批准号:
    6302834
  • 财政年份:
    2000
  • 资助金额:
    $ 19.13万
  • 项目类别:
ACTG 301--MEMANTINE FOR AIDS DEMENTIA COMPLEX WITH ANTIRETROVIRAL THERAPY
ACTG 301--美金刚联合抗逆转录病毒疗法治疗艾滋病痴呆症
  • 批准号:
    6468094
  • 财政年份:
    2000
  • 资助金额:
    $ 19.13万
  • 项目类别:
ROLE OF KUNURENINE PATHWAY METABOLITES IN THE PATHOGEN-ESIS OF THE AIDS DEMENTIA COMPLEX
昆仑氨酸途径代谢物在艾滋病痴呆症发病中的作用
  • 批准号:
    nhmrc : 7484
  • 财政年份:
    2000
  • 资助金额:
    $ 19.13万
  • 项目类别:
    CARG - People
PHASE II TRIAL OF MEMANTINE FOR AIDS DEMENTIA COMPLEX (ACTG301)
美金刚治疗艾滋病痴呆症的二期试验 (ACTG301)
  • 批准号:
    6568641
  • 财政年份:
    2000
  • 资助金额:
    $ 19.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了